Showing 2331-2340 of 2656 results for "".
- Johnson & Johnson Vision Presents New Myopia Progression and Contact Lens Findings at American Academy of Optometry Annual Meetinghttps://modernod.com/news/johnson-johnson-vision-presents-new-myopia-progression-and-contact-lens-findings-at-american-academy-of-optometry-annual-meeting/2478387/Johnson & Johnson Vision announced clinical data from the latest in myopia research at the American Academy of Optometry’s virtual annual meeting (Academy 2020). Investigators will also reveal findings that demonstrate how Acuvue Oasys 1-Day with Hydraluxe Technology Contact Lenses redu
- Dell, HP, Lenovo and Acer to Announce New Eyesafe Products at the Blue Light Summit 2020https://modernod.com/news/dell-hp-lenovo-and-acer-to-announce-new-eyesafe-products-at-the-blue-light-summit-2020/2478378/Eyesafe, UnitedHealthcare Vision, and TÜV Rheinland Group announced the dates and registration details as well as the initial lineup of companies and thought leaders participating in the Blue Light Summit 2020. This year’s event will be held on Oct. 15, 2020. D
- Kodiak Sciences Treats First Patients in Three Phase 3 Studies of KSI-301 for Retinal Diseaseshttps://modernod.com/news/kodiak-sciences-treats-first-patients-in-three-phase-3-studies-of-ksi-301-for-retinal-diseases/2478361/Kodiak Sciences announced that the first patients have been treated in the randomized, double-masked GLEAM, GLIMMER, and BEACON studies, three pivotal phase 3 studies of KSI-301, Kodiak’s anti-VEGF antibody biopolymer conjugate, in treatment-naïve patients with diabetic macular edema (GLEAM
- Bristol, Amgen, Teva CEOs Among Execs to Testify at House Drug Pricing Hearings Next Weekhttps://modernod.com/news/bristol-amgen-teva-ceos-among-execs-to-testify-at-house-drug-pricing-hearings-next-week/2478346/After the late Rep. Elijah Cummings launched a drug pricing probe of some of the industry’s largest players last January, six pharmaceutical execs are set to head to Washington next week for hearings at the House Committee on Oversight and Reform, according to
- Bausch Health Acquires Option To Purchase Ophthalmology Assets Of Allegro Ophthalmicshttps://modernod.com/news/bausch-health-to-acquire-option-to-purchase-all-ophthalmology-assets-of-allegro-ophthalmics/2478300/Bausch Health has entered into an agreement to acquire an option to purchase all ophthalmology assets of Allegro Ophthalmics, including global rights for risuteganib (Luminate)1, Allegro’s lead investigational compound in retina. Full financial terms of the deal were not d
- Oxford Says AstraZeneca Trial Illnesses May Not Be Linked to COVID-19 Vaccinehttps://modernod.com/news/oxford-says-astrazeneca-trial-illnesses-may-not-be-linked-to-covid-19-vaccine/2478290/Neurological symptoms developed by some volunteers in a trial testing AstraZeneca’s COVID-19 vaccine candidate AZD1222 either probably did not come about as a result of the vaccine, or there is not enough evidence to say one way or the other, according to the University of Oxford. The discl
- US Plans to Ship First Coronavirus Vaccines Within 24 Hours of FDA Approvalhttps://modernod.com/news/us-plans-to-ship-first-coronavirus-vaccines-within-24-hours-of-fda-approval/2478291/US officials on Wednesday indicated that a COVID-19 vaccine will start to be distributed within about 24 hours after a license or emergency-use authorization (EUA) is issued. Paul Ostrowski, who is overseeing logistics for the US government’s Operation Warp Speed initiative, said that the o
- FDA Probes Whether to Allow AstraZeneca to Resume COVID-19 Vaccine Trial in UShttps://modernod.com/news/fda-probes-whether-to-allow-astrazeneca-to-resume-covid-19-vaccine-trial-in-us/2478286/The FDA is looking into whether they should follow their UK counterparts in allowing a phase 3 study of AstraZeneca’s COVID-19 vaccine to resume after it had been temporarily suspended last week when a trial participant in the UK was said to have suffered spinal cord inflammation. AstraZene
- AEYE Health Develops Advanced AI-Based Retinal Screening With Instant Resultshttps://modernod.com/news/aeye-health-develops-advanced-ai-based-retinal-screening-with-instant-results/2478232/AEYE Health has developed an AI-based retinal screening system that provides analysis and diagnostic results within 60 seconds. AEYE Health’s advanced machine learning and artificial intelligence technologies offer instant and accurate screening and analysis of the retina for the det
- Practitioners Should Be Aware of Mask-Associated Dry Eye (MADE)https://modernod.com/news/core-alerts-practitioners-to-mask-associated-dry-eye-made/2478221/Widespread use of face masks has been determined essential to combat COVID-19’s spread, yet is giving rise to a new phenomenon: increased reports of dry eyes. Experts from the Centre for Ocular Research & Education (CORE) are advising eye care professionals on how to recognize mask-associated